Alder BioPharmaceuticals, Inc. (ALDR) Financial Statements (2024 and earlier)

Company Profile

Business Address 11804 NORTH CREEK PARKWAY SOUTH
BOTHELL, WA 98011
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2019
MRQ
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 407,369276,240351,867305,17255,872
Cash and cash equivalents 87,86576,896116,216206,49246,795
Short-term investments 319,504199,344235,65198,6809,077
Restricted cash and investments 5,000    
Receivables     113
Inventory, net of allowances, customer advances and progress billings   936  
Inventory   936  
Other undisclosed current assets 7,44011,01440,38017,0294,758
Total current assets: 419,809287,254393,183322,20160,743
Noncurrent Assets
Property, plant and equipment 6,4005,6307,0761,9741,160
Long-term investments and receivables  22286575,840 
Long-term investments  22286575,840 
Restricted cash and investments  10,000   
Other noncurrent assets 30308,030122,456
Total noncurrent assets: 6,43015,88215,97177,8263,616
TOTAL ASSETS: 426,239303,136409,154400,02764,359
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 28,16223,27425,79812,3107,085
Employee-related liabilities     2,211
Accounts payable 8,9457,47110,3614,7271,911
Accrued liabilities 19,21715,80315,4377,5832,963
Deferred rent credit 74
Deferred revenue and credits929262135
Other undisclosed current liabilities     (2,211)
Total current liabilities: 28,23623,36625,89012,3725,009
Noncurrent Liabilities
Long-term debt and lease obligation 182,104    
Long-term debt, excluding current maturities 182,104    
Liabilities, other than long-term debt 510495481138193
Deferred revenue and credits495481138193
Deferred rent credit 510
Other undisclosed noncurrent liabilities 1,658    
Total noncurrent liabilities: 184,272495481138193
Total liabilities: 212,50823,86126,37112,5105,202
Equity
Equity, attributable to parent 109,976279,275382,783387,51759,157
Common stock 77543
Additional paid in capital 1,074,963946,869761,456610,390196,082
Accumulated other comprehensive loss (1,056)(92)(48)(501)(22)
Accumulated deficit (963,938)(667,509)(378,630)(222,376)(136,906)
Other undisclosed equity 103,755    
Total equity: 213,731279,275382,783387,51759,157
TOTAL LIABILITIES AND EQUITY: 426,239303,136409,154400,02764,359

Income Statement (P&L) ($ in thousands)

6/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues 3001,619113 54,705
Revenue, net1,619113 54,705
Gain on disposition of assets for financial service operations 300
Cost of revenue
(Cost of Goods and Services Sold)
   (113)  
Gross profit: 3001,619  54,705
Operating expenses (286,582)(292,623)(158,908)(86,329)(45,901)
Other undisclosed operating income (loss) (300) 1,050  
Operating income (loss): (286,582)(291,004)(157,858)(86,329)8,804
Nonoperating income (expense) (9,625)2,7681,789859104
Investment income, nonoperating 8,9092,4951,96670244
Gain (loss), foreign currency transaction, before tax 309223(349)73 
Other nonoperating income  501728460
Interest and debt expense (17,185)    
Other undisclosed income from continuing operations before equity method investments, income taxes 17,185    
Income (loss) from continuing operations before equity method investments, income taxes: (296,207)(288,236)(156,069)(85,470)8,908
Loss from equity method investments (222)(643)(185)  
Income (loss) from continuing operations: (296,429)(288,879)(156,254)(85,470)8,908
Income (loss) before gain (loss) on sale of properties: (296,429)(288,879)(156,254)(85,470)8,908
Net income (loss) attributable to parent: (296,429)(288,879)(156,254)(85,470)8,908
Other undisclosed net loss available to common stockholders, basic (35,505)    
Net income (loss) available to common stockholders, diluted: (331,934)(288,879)(156,254)(85,470)8,908

Comprehensive Income ($ in thousands)

6/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net income (loss): (296,429)(288,879)(156,254)(85,470)8,908
Other comprehensive income (loss) (964)(44)453(479)(31)
Comprehensive income (loss), net of tax, attributable to parent: (297,393)(288,923)(155,801)(85,949)8,877

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: